Finance

Lists
Why is CLN down 2,16%?
Dive Deeper
CLN:WSE
Celon Pharma SA
PLN 16,30
-2,16%
(-0,36) 1D
6 Nov., 17:04:09 GMT+1  ·   PLN
All symbols
SymbolPriceChange% Change
Generating top insights for CLN...
Open
PLN 16,40
High
PLN 16,86
Low
PLN 16,16
Mkt. cap
878,76 m
Avg. vol.
23,82 k
Volume
31,07 k
P/E ratio
7,94
52-wk high
PLN 23,50
52-wk low
PLN 15,92
EPS
PLN 2,05
Shares outstanding
53,91 m
No. of employees
560
Open
PLN 16,40
High
PLN 16,86
Low
PLN 16,16
Mkt. cap
878,76 m
Avg. vol.
23,82 k
Volume
31,07 k
P/E ratio
7,94
52-wk high
PLN 23,50
52-wk low
PLN 15,92
EPS
PLN 2,05
Shares outstanding
53,91 m
No. of employees
560
News stories
From web sources and news partners
About Celon Pharma SA
CEO-
Employees560
Founded2002
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitecelonpharma.com
Next call oor 9 dae
Wo. 18 Nov., 06:35
Fiscal period
Q3 2026
- / -
Revenue / Est. (PLN)
- / 63,50 m
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in PLN
Loading Previous Earnings...
Revenue
Net income
All values in PLN
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
71,13 m
66,67 m
65,26 m
55,57 m
Cost of goods sold
16,83 m
11,54 m
16,70 m
14,92 m
Cost of revenue
16,83 m
11,54 m
16,70 m
14,92 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
33,02 m
35,44 m
36,08 m
38,62 m
Operating expense
46,24 m
52,60 m
54,54 m
50,11 m
Total operating expenses
63,07 m
64,14 m
71,23 m
65,04 m
Operating income
8,06 m
2,53 m
-5,98 m
-9,46 m
Other non operating income
-30,00 k
-250,00 k
169,05 m
3,48 m
EBT including unusual items
-2,77 m
-6,57 m
160,34 m
-7,38 m
EBT excluding unusual items
-2,77 m
-6,57 m
160,34 m
-7,38 m
Income tax expense
-6,43 m
18,33 m
1,70 m
23,21 m
Effective tax rate
232,29%
-279,14%
1,06%
-314,48%
Other operating expenses
2,20 m
6,37 m
7,33 m
1,36 m
Net income
3,66 m
-24,90 m
158,64 m
-30,59 m
Net profit margin
5,15%
-37,35%
243,09%
-55,05%
Earnings per share
-
-
-
-
Interest and investment income
-
149,00 k
151,00 k
151,00 k
Interest expense
-
-341,00 k
-915,00 k
-1,55 m
Net interest expenses
-
-192,00 k
-764,00 k
-1,40 m
Depreciation and amortization charges
11,01 m
10,78 m
11,13 m
10,13 m
EBITDA
16,34 m
11,40 m
3,44 m
-748,00 k
Gain or loss from assets sale
-170,00 k
-2,91 m
-569,00 k
716,00 k
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme